Literature DB >> 20304630

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth.

Dalit Barkan1, Jeffrey E Green, Ann F Chambers.   

Abstract

Metastases can develop after apparently successful treatment of a primary tumour, sometimes following a period of tumour dormancy that can last for years. However, factors that regulate metastatic tumour dormancy remain poorly understood. Here we review the potential contribution of interactions between tumour cells and the microenvironment in metastatic sites, in regulating tumour dormancy vs. metastatic growth. We focus particularly on the potential role of the extracellular matrix (ECM) in regulating maintenance and release from dormancy. Tumour cells that fail to properly adhere to the ECM may enter a state of dormancy. The molecular and physical composition of the ECM can be affected by tumour cells themselves, as well as multiple stromal cell types. The roles of integrins, fibronectin, and collagen are discussed, as are factors that can change the ECM. A better understanding of the molecular details of the crosstalk between tumour cells and the ECM in secondary sites, and how these regulate the dormant state, may lead to improved therapeutic strategies to induce or maintain disseminated tumour cells in a dormant state, or alternatively to successfully eradicate dormant cells. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20304630      PMCID: PMC2856784          DOI: 10.1016/j.ejca.2010.02.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  73 in total

Review 1.  Dormancy of solitary metastatic cells.

Authors:  Jason L Townson; Ann F Chambers
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

Review 2.  Modifying the soil to affect the seed: role of stromal-derived matrix metalloproteinases in cancer progression.

Authors:  Sonata Jodele; Laurence Blavier; Janet M Yoon; Yves A DeClerck
Journal:  Cancer Metastasis Rev       Date:  2006-03       Impact factor: 9.264

3.  Macrophage elastase (matrix metalloproteinase-12) suppresses growth of lung metastases.

Authors:  A McGarry Houghton; Jay L Grisolano; Mary L Baumann; Dale K Kobayashi; R Dean Hautamaki; Leslie C Nehring; Lynn A Cornelius; Steven D Shapiro
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 4.  Addressing the role of cell adhesion in tumor cell dormancy.

Authors:  Donald E White; Jonathan H Rayment; William J Muller
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

5.  A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype.

Authors:  George N Naumov; Elise Bender; David Zurakowski; Soo-Young Kang; David Sampson; Evelyn Flynn; Randolph S Watnick; Oddbjorn Straume; Lars A Akslen; Judah Folkman; Nava Almog
Journal:  J Natl Cancer Inst       Date:  2006-03-01       Impact factor: 13.506

6.  Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics.

Authors:  Christoph A Klein; Dieter Hölzel
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

7.  Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients.

Authors:  Yumei Feng; Baocun Sun; Xiaoqing Li; Liang Zhang; Yun Niu; Chunhua Xiao; Liansheng Ning; Zhiyi Fang; Yuli Wang; Lina Zhang; Jing Cheng; Wei Zhang; Xishan Hao
Journal:  Breast Cancer Res Treat       Date:  2006-11-23       Impact factor: 4.872

Review 8.  Immune-mediated dormancy: an equilibrium with cancer.

Authors:  Michele W L Teng; Jeremy B Swann; Catherine M Koebel; Robert D Schreiber; Mark J Smyth
Journal:  J Leukoc Biol       Date:  2008-05-30       Impact factor: 4.962

9.  Seeding and propagation of untransformed mouse mammary cells in the lung.

Authors:  Katrina Podsypanina; Yi-Chieh Nancy Du; Martin Jechlinger; Levi J Beverly; Dolores Hambardzumyan; Harold Varmus
Journal:  Science       Date:  2008-08-28       Impact factor: 47.728

10.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.

Authors:  Rosandra N Kaplan; Rebecca D Riba; Stergios Zacharoulis; Anna H Bramley; Loïc Vincent; Carla Costa; Daniel D MacDonald; David K Jin; Koji Shido; Scott A Kerns; Zhenping Zhu; Daniel Hicklin; Yan Wu; Jeffrey L Port; Nasser Altorki; Elisa R Port; Davide Ruggero; Sergey V Shmelkov; Kristian K Jensen; Shahin Rafii; David Lyden
Journal:  Nature       Date:  2005-12-08       Impact factor: 49.962

View more
  160 in total

1.  Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: growth inhibition, quiescence, and recovery.

Authors:  Brian I Carr; Aldo Cavallini; Catia Lippolis; Rosalba D'Alessandro; Caterina Messa; Maria G Refolo; Angela Tafaro
Journal:  J Cell Physiol       Date:  2013-02       Impact factor: 6.384

2.  Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.

Authors:  Lara H El Touny; Anthony Vieira; Arnulfo Mendoza; Chand Khanna; Mark J Hoenerhoff; Jeffrey E Green
Journal:  J Clin Invest       Date:  2013-12-09       Impact factor: 14.808

3.  Expression of metastasis suppressor BRMS1 in breast cancer cells results in a marked delay in cellular adhesion to matrix.

Authors:  Yekaterina B Khotskaya; Benjamin H Beck; Douglas R Hurst; Zhenbo Han; Weiya Xia; Mien-Chie Hung; Danny R Welch
Journal:  Mol Carcinog       Date:  2013-09-02       Impact factor: 4.784

Review 4.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

5.  Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway.

Authors:  Nikolas Balanis; Michael K Wendt; Barbara J Schiemann; Zhenghe Wang; William P Schiemann; Cathleen R Carlin
Journal:  J Biol Chem       Date:  2013-05-07       Impact factor: 5.157

Review 6.  The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.

Authors:  Robert R Langley; Isaiah J Fidler
Journal:  Int J Cancer       Date:  2011-03-25       Impact factor: 7.396

Review 7.  Significance of talin in cancer progression and metastasis.

Authors:  Andreas Desiniotis; Natasha Kyprianou
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

8.  Quantification of cancer cell extravasation in vivo.

Authors:  Yohan Kim; Karla C Williams; Carson T Gavin; Emily Jardine; Ann F Chambers; Hon S Leong
Journal:  Nat Protoc       Date:  2016-04-21       Impact factor: 13.491

9.  Arp2/3 Complex Is Required for Macrophage Integrin Functions but Is Dispensable for FcR Phagocytosis and In Vivo Motility.

Authors:  Jeremy D Rotty; Hailey E Brighton; Stephanie L Craig; Sreeja B Asokan; Ning Cheng; Jenny P Ting; James E Bear
Journal:  Dev Cell       Date:  2017-08-31       Impact factor: 12.270

10.  Primary tumor regulates the pulmonary microenvironment in melanoma carcinoma model and facilitates lung metastasis.

Authors:  Mingyong Han; Jiying Xu; Yuli Bi; Man Jiang; Xiaoya Xu; Qi Liu; Jihui Jia
Journal:  J Cancer Res Clin Oncol       Date:  2012-08-19       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.